UK-BASED SUPPLIER · ESTABLISHED 2023
Research-grade peptides, verified by third-party analysis.
Supplied to independent researchers, academic laboratories, and accredited institutions. Purity verified by HPLC and mass spectrometry on every batch.
≥98%
HPLC PURITY
3pm
DISPATCH CUT-OFF
-20°C
COLD CHAIN
COA
PER BATCH
Most studied compounds
Latest from the peptide industry
Reputational Risks
FDA's September 2026 Peptide Vendor Sweep: Five Warning Letters, the "Research-Use Only" Labelling Test, and What It Means for Legitimate Suppliers
On 1 September 2026, the FDA published five simultaneous warning letters to online peptide sellers, citing the illegal marketing of injectable semaglutide, tirzepatide, retatrutide, tesamorelin and other unapproved compounds. The sweep expands an established enforcement pattern and clarifies how regulators assess "research-use only" claims — with direct implications for compliant research-grade suppliers in the UK and US.
22 Sep 2026
Industry & Community
The Oral Peptide Delivery Race: Approvals, Formulation Science, and the Investment Wave Reshaping Drug Development in 2026
A cluster of FDA approvals, landmark partnership deals, and oversubscribed financing rounds in 2026 signals that oral delivery of peptide therapeutics is transitioning from a persistent scientific aspiration to a commercially credible drug class. Research-procurement teams sourcing peptide APIs and formulation materials need to understand the technical and market forces now driving this shift.
21 Sep 2026
Regulatory & Policy
Eight Days Left: FDA's 17 Revised Draft Peptide Guidances and What the Withdrawn 2021 Framework Means for Generic Developers
The FDA published 17 revised draft product-specific guidances for generic peptide products on 28 July 2026, covering semaglutide, tirzepatide, liraglutide, teriparatide and 13 other reference drugs. The public comment window closes on 28 September 2026 — eight days from today. The agency simultaneously withdrew its May 2021 synthetic-peptide guidance, leaving sponsors mid-programme without a replacement framework until later in 2026.
20 Sep 2026
Every batch, documented.
HPLC purity analysis, mass spectrometry confirmation, and batch traceability — downloadable per product, matched to the batch code on your vial.
View our methodology →
Cold chain maintained.
Lyophilised product held at -20°C in temperature-controlled storage from receipt to dispatch. Stability guaranteed under documented conditions.
Storage protocols →
Same-day, plain packaging.
Orders placed before 3pm, Monday to Friday, dispatched the same working day. Tracked UK delivery, discreet unbranded packaging as standard.
Shipping & returns →